H.R. 4832 — Prescription Drug Comparative Effectiveness Act of 2002

Summary

Prescription Drug Comparative Effectiveness Act of 2002 - Directs the Director of the Agency for Healthcare Research and Quality to study, analyze, and report to Congress on valid scientific evidence regarding the comparative effectiveness and cost-effectiveness, relative to other drugs and treatments, of prescription drugs that account for high levels of expenditures or use by individuals entitled to benefits under titles XVIII (Medicare) or XIX (Medicaid) of the Social Security Act.

Full Text

Legislative Actions

2002-05-23
Introduced in House
2002-05-23
Introduced in House
2002-05-23
Referred to the House Committee on Energy and Commerce.
2002-06-03
Referred to the Subcommittee on Health.

Prescription Drug Comparative Effectiveness Act of 2002

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill